image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Tarsus - Much stronger outlook, still very cheap

February 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TRS
  • Price:
  • 136p
he shares finally woke up after Tarsus  announced trading “comfortably†in line, with like-for-like revenue growth of 6% for the year to 31 December, while net debt fell to a lower than expected £29m. Full year results are due on 7 March.There were plenty of positives and a feeling that prospects are significantly brighter, with the improving trends witnessed in Q4 continuing into 2011. In emerging markets, MEBA (business jets) held in Dubai enjoyed  revenues up 40% with visitor numbers rising 13% while  Labelexpo India rose 22% and 27% respectively. In the USA the key medical division grew 18%, slightly ahead of expectations. The key going forward is that its two largest biennial events, Labelexpo Europe ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X